Jiřı́ Mayer
Forschungszentrum Jülich(DE)Ernst Ruska Centre(DE)RWTH Aachen University(DE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013(2013)1,979 cited
- → Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial(2010)1,860 cited
- → Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.(2011)1,622 cited
- → Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia(2010)1,574 cited
- → Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia(2015)1,539 cited
- → Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial(2016)926 cited